| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2005.11.031 |
| P698 | PubMed publication ID | 16356600 |
| P2093 | author name string | Yeongjin Hong | |
| Hyon E Choy | |||
| Joon Haeng Rhee | |||
| Hyun Ju Kim | |||
| Hyun-Chul Lee | |||
| Hee Sam Na | |||
| P2860 | cites work | Molecular analysis of spv virulence genes of the salmonella virulence plasmids | Q29042112 |
| Salmonella pathogenicity islands: big virulence in small packages. | Q33878633 | ||
| Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells | Q34298444 | ||
| Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain? | Q34469798 | ||
| Expression of Salmonella typhimurium rpoS and rpoS-dependent genes in the intracellular environment of eukaryotic cells | Q35529666 | ||
| Synergistic effect of mutations in invA and lpfC on the ability of Salmonella typhimurium to cause murine typhoid. | Q35549256 | ||
| Mucosal immunity: implications for vaccine development | Q36117069 | ||
| Synthesis of the stationary-phase sigma factor sigma s is positively regulated by ppGpp | Q36124805 | ||
| Salmonella stress management and its relevance to behaviour during intestinal colonisation and infection | Q36197324 | ||
| The route of enteric infection in normal mice | Q36273394 | ||
| Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. | Q36363455 | ||
| A genetic locus for the regulation of ribonucleic acid synthesis | Q36442193 | ||
| The alternative sigma factor katF (rpoS) regulates Salmonella virulence | Q37346357 | ||
| Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium | Q37698755 | ||
| Origin and differentiation of lymphocytes involved in the secretory IgA responses | Q39448606 | ||
| Type III secretion chaperone-dependent regulation: activation of virulence genes by SicA and InvF in Salmonella typhimurium. | Q39645093 | ||
| Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. | Q40157396 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Non-invasive Salmonella typhimurium mutants are avirulent because of an inability to enter and destroy M cells of ileal Peyer's patches | Q40651358 | ||
| Production of immunity and unresponsiveness in the mouse by feeding contact sensitizing agents and the role of suppressor cells in the Peyer's patches, mesenteric lymph nodes and other lymphoid tissues | Q40657187 | ||
| Back to log phase: sigma S as a global regulator in the osmotic control of gene expression in Escherichia coli | Q41181646 | ||
| hilA is a novel ompR/toxR family member that activates the expression of Salmonella typhimurium invasion genes | Q42638991 | ||
| The bacterial signal molecule, ppGpp, regulates Salmonella virulence gene expression | Q44928503 | ||
| Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium | Q46564311 | ||
| The Salmonella typhimurium invasion genes invF and invG encode homologues of the AraC and PulD family of proteins | Q48080387 | ||
| The putative invasion protein chaperone SicA acts together with InvF to activate the expression of Salmonella typhimurium virulence genes | Q50122261 | ||
| Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains | Q50127085 | ||
| Salmonella SirA is a global regulator of genes mediating enteropathogenesis | Q50127381 | ||
| Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression | Q50136962 | ||
| The stationary-phase sigma factor sigma S (RpoS) is required for a sustained acid tolerance response in virulent Salmonella typhimurium | Q50143287 | ||
| Live oral avirulent Salmonella vaccines | Q50157012 | ||
| Virulence and vaccine potential of phoP mutants of Salmonella typhimurium | Q50195223 | ||
| Control of RNA synthesis in Escherichia coli. I. Amino acid dependence of the synthesis of the substrates of RNA polymerase. | Q53984482 | ||
| Regulation through the Secondary Channel—Structural Framework for ppGpp-DksA Synergism during Transcription | Q57895265 | ||
| RpoS-dependent promoters require guanosine tetraphosphate for induction even in the presence of high levels of sigma(s) | Q73626179 | ||
| DksA: a critical component of the transcription initiation machinery that potentiates the regulation of rRNA promoters by ppGpp and the initiating NTP | Q80417641 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| P304 | page(s) | 2027-2034 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Immune response induced by Salmonella typhimurium defective in ppGpp synthesis | |
| P478 | volume | 24 |
| Q34058992 | A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypes |
| Q34654013 | A novel balanced-lethal host-vector system based on glmS. |
| Q33914020 | Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium |
| Q64946431 | Bacteria in Cancer Therapeutics: A Framework for Effective Therapeutic Bacterial Screening and Identification. |
| Q98772185 | Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer |
| Q50333648 | Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions |
| Q35562522 | Characterization of the RelBbu Regulon in Borrelia burgdorferi Reveals Modulation of Glycerol Metabolism by (p)ppGpp |
| Q30360446 | Cholera toxin production during anaerobic trimethylamine N-oxide respiration is mediated by stringent response in Vibrio cholerae. |
| Q33777377 | Comparative proteomic analysis of Salmonella enterica serovar Typhimurium ppGpp-deficient mutant to identify a novel virulence protein required for intracellular survival in macrophages |
| Q37696851 | Compensation of fitness costs and reversibility of antibiotic resistance mutations |
| Q89947898 | Development of Oxytolerant Salmonella typhimurium Using Radiation Mutation Technology (RMT) for Cancer Therapy |
| Q50025874 | Effect of Salmonella treatment on an implanted tumor (CT26) in a mouse model |
| Q35273267 | Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains |
| Q34994526 | Engineering and visualization of bacteria for targeting infarcted myocardium |
| Q42838131 | Immune response induced by ppGpp-defective Salmonella enterica serovar Gallinarum in chickens |
| Q39662683 | Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice |
| Q27003066 | Live attenuated vaccines for invasive Salmonella infections |
| Q38813137 | Plague Vaccines: Status and Future |
| Q37405767 | Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants. |
| Q37640815 | Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines |
| Q36994425 | Regulation of cell growth during serum starvation and bacterial survival in macrophages by the bifunctional enzyme SpoT in Helicobacter pylori. |
| Q37152941 | Ribosome•RelA structures reveal the mechanism of stringent response activation. |
| Q36163108 | Role of RelA and SpoT in Burkholderia pseudomallei virulence and immunity |
| Q97521630 | Salmonella Typhimurium Lacking YjeK as a Candidate Live Attenuated Vaccine Against Invasive Salmonella Infection |
| Q90618645 | Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy |
| Q39339432 | Salmonella-Mediated Cancer Therapy: Roles and Potential |
| Q28069354 | Targeted Cancer Therapy Using Engineered Salmonella typhimurium |
| Q34129364 | The architecture and ppGpp-dependent expression of the primary transcriptome of Salmonella Typhimurium during invasion gene expression |
| Q50077977 | The bacterial signal molecule, ppGpp, mediates the environmental regulation of both the invasion and intracellular virulence gene programs of Salmonella |
| Q36116601 | The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma |
| Q35273242 | The stringent response is essential for Pseudomonas aeruginosa virulence in the rat lung agar bead and Drosophila melanogaster feeding models of infection |
| Q58599910 | Tumour-targeting bacteria engineered to fight cancer |
| Q47587450 | Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin |
| Q33909091 | ppGpp conjures bacterial virulence |
Search more.